Chemotherapy with Gemcitabine and Oxaliplatin in Patients with Advanced Biliary Tract Cancer: A Single-Institution Experience

Publisher： Karger

E-ISSN： 1423-0232|73|5-6|311-315

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.5-6, 2008-05, pp. : 311-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature

By  

Oncology, Vol. 91, Iss. 4, 2016-08 ,pp. : 211-216

Karger

Access to resources Recommend Favorite

Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer:A Retrospective Study

By  

Case Reports in Oncology, Vol. 3, Iss. 3, 2010-12 ,pp. : 498-504

Karger

Access to resources Recommend Favorite

Chemotherapy with Gemcitabine in Advanced Biliary Tract Carcinoma

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 1, 2008-01 ,pp. : 70-78

Bentham Science Publishers

Access to resources Recommend Favorite

Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1671-1675

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemcitabine Combined with Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Patients with Advanced Ovarian Cancer Refractory or Resistant to Platinum and Taxane

By  

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 376-381

Karger

Access to resources Recommend Favorite